the most common side effects of Wegovy may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, gas, stomach flu and heartburn
This disparity raises a critical question for practitioners: How can one responsibly bridge the gap between compelling mechanistic promise and the current realities of the clinical evidence
The idea of how it works is that it helps grow new tiny blood vessels in healing tissue, nudges growth signals where you are hurt, and plays with the nitric-oxide system that matters for both the gut and blood vessels
This potential effect on inflammation has led some scientists to wonder if semaglutide might help people with inflammatory diseases such as RA
The EFTEM images before and after edges were obtained using a slit width of 35 eV and 20 datasets were collected for each window before and after the edge at 815 eV, 855 eV and 899 eV
Phase 2 obesity trial (NEJM 2023) adverse events by maintenance dose (where a dose had two escalation arms, the range across both arms is shown): Phase 2 type 2 diabetes trial (Lancet 2023): mild-to-moderate gastrointestinal adverse events (nausea, diarrhea, vomiting, constipation) were reported in 35% of retatrutide participants ranging from 13% at 0.5 mg to 50% in the 8 mg fast-escalation group compared with 13% on placebo and 35% on dulaglutide 1.5 mg
